Objectives: Upon completion, learners will be able to:
Describe the pathophysiology of twin-to-twin transfusion (TTT).
Outline the steps in diagnosing TTT.
Identify the stages of TTT.
Discuss the management of TTT syndrome (TTTS).
Purpose of this CE Activity: The purpose of this article is to present a case of a twin-to-twin transfusion syndrome within the rare population group of monochorionic, monoamniotic twin gestation. Neonatal providers and nurses will be able to understand the vascular architecture, circulation pathophysiology of the anastomoses, and staging of the disease to better manage the infants after delivery.
Requirements for Completion: The following requirements are necessary for successful completion of this CNE activity.
Access to a computer with an Internet connection
Pass the posttest with a score of 80%
Complete and submit the evaluation for this CNE activity
Accreditation Provider, Academy of Neonatal Nursing, approved by the California Board of Registered Nursing, Provider #CEP 6261; and Florida Board of Nursing, Provider #FBN 3218, content code 2505.
The Academy of Neonatal Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Release Date: September/October 2018 Review Date: September 2021 Expiration Date: September 30, 2021
This CNE activity has been reviewed by the Lead Nurse Planner. It has been determined that the material presented here shows no bias.
The content of this CNE activity has been developed by the planning committee and has been reviewed by the Lead Nurse Planner.
Disclaimer: The Academy of Neonatal Nursing assumes no responsibility or liability for the content presented. Care of the infant should always be individualized and no one source relied upon for information regarding aspects of care. Accredited status does not imply endorsement by ANN, ANA, or the American Nurses Credentialing Center of any commercial products displayed or discussed in conjunction with an educational activity.
You must be logged in and own this product in order to post comments.
11/26/18 12:26 pm
Hi, I am pretty sure there is a mistake/need of clarification in the article. On page 296 under Recipient twin; that there " high level of these circulating peptide hormones increase renal perfusion & filtration in an attempt to decrease tubular re absorption of fluid"
It is implied in previous sentence that ADH/antidiuretic hormone is also increased. I few different sources I checked state ADH (specifically) is decreased or suppressed to allow for MORE diuresis. Subsequently; there is then a question that specifically asks which hormone is increased with ADH as an answer.... again I believe its decreased. It didnt quite make sense to me so I checked on a few different sources.
If I am wrong I apologize!
Susan Small, MSN, APRN, NNP-BC, IBCLC